LIVERFASt-LFS NIT for Fatty Liver Disease, for Primary Care Provider (PCP) screening
LIVERFASt-LFS NIT for Fatty Liver Disease, for Primary Care Provider (PCP) screening
Assessment of Fatty Liver Disease using LIVERFASt in South-East Asia (real-world evidence)
Assessment of Fatty Liver Disease using LIVERFASt in South-East Asia (real-world evidence)
Predictive Value of LIVERFASt, ARFI-FIB-4 to identify chronic Hepatitis B (CHB) — NUH Singapore cohort
Predictive Value of LIVERFASt, ARFI-FIB-4 to identify chronic Hepatitis B (CHB) — NUH Singapore cohort
Comparative Performances of LIVERFASt, Fibroscan and other NITs for severe fibrosis in NAFLD patients (Bordeaux cohort)
Comparative Performances of LIVERFASt, Fibroscan and other NITs for severe fibrosis in NAFLD patients (Bordeaux cohort)
Simulating clinical confidence intervals for black-box algorithmic predictions of liver steatosis
Simulating clinical confidence intervals for black-box algorithmic predictions of liver steatosis
Comparison analysis of FIB-4, LIVERFASt, LSM in Sequential and Combinatory Pathways for NAFLD
Comparison analysis of FIB-4, LIVERFASt, LSM in Sequential and Combinatory Pathways for NAFLD
Long-term prognosis of MAFLD patients according to non-invasive methods
Long-term prognosis of MAFLD patients according to non-invasive methods
Noninvasive LIVERFASt transition rate to liver fibrosis, similar to liver biopsy in NAFLD patients
Noninvasive LIVERFASt transition rate to liver fibrosis, similar to liver biopsy in NAFLD patients
Repeated noninvasive liver biopsy surrogate LIVERFASt correlates with BMI and liver enzyme improvements (regression poster)
Repeated noninvasive liver biopsy surrogate LIVERFASt correlates with BMI and liver enzyme improvements
Comparative Assessment of NIMs (LIVERFASt/ELF/FIB-4/LSM) in a prospective cohort with chronic liver diseases (Thailand)
Comparative Assessment of NIMs (LIVERFASt/ELF/FIB-4/LSM) in a prospective cohort with chronic liver diseases (Thailand)